date,title,source
Nov-13-18,"Detailed Research: Economic Perspectives on Pernix Therapeutics, Hallador Energy, Vince Holding, Tuesday Morning, Information Services Group, and Sienna Biopharmaceuticals  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Dec-03-18,"Sienna Biopharmaceuticals Announces Its Topical, Non-Steroidal TrkA Inhibitor SNA-120 (0.05%) Demonstrated Significant Impact on Psoriasis in Phase 2b Study and Plans to Initiate Phase 3 Psoriasis Trials in Second Half of 2019",GlobeNewswire
Dec-06-18,Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference,GlobeNewswire
Dec-25-18,"Do Directors Own Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) Shares?",Simply Wall St.
Feb-08-19,4 Tech Stocks Leading The Pack On Friday (2/8/19),ACCESSWIRE
Feb-08-19,Sienna Biopharmaceuticals Novel Silver Photoparticle Technology SNA-001 Successfully Removes Light Hair When Used with Common Laser System,GlobeNewswire
Feb-19-19,Sienna Biopharmaceuticals Announces Proposed Public Offering of Common Stock,GlobeNewswire
Feb-20-19,Why A Secondary Offering Is Often Negative For Stocks,Benzinga
Feb-20-19,Sienna Biopharmaceuticals Prices Public Offering of Common Stock,GlobeNewswire
Feb-20-19,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",Benzinga
